SCHEMBL28279253

SCHEMBL28279253

COc1cccc(-c2nnccc2C)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 1/20 0.51
CLK4 Q9HAZ1 1/20 0.51
NOTUM Q6P988 1/20 0.49
GAA P10253 1/20 0.47
TP53 P04637 2/20 0.45
HPGD P15428 2/20 0.45
HTT P42858 1/20 0.45
KMT2A Q03164 2/20 0.44
NISCH Q9Y2I1 1/20 0.44
KDM4E B2RXH2 1/20 0.44
DPP4 P27487 1/20 0.44
MAPT P10636 2/20 0.43
RAB9A P51151 2/20 0.43
MEN1 O00255 1/20 0.43
NPC1 O15118 1/20 0.43
ALDH1A1 P00352 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
LMNA P02545 1/20 0.43
TSHR P16473 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10094648 0.79 DYRK1A (0.62) DYRK1ACLK4GAAHPGDNISCH
SCHEMBL28277835 0.77 ADORA2A (0.46) NOTUMGAANISCHKDM4EDPP4
SCHEMBL7944851 0.73 DYRK1A (0.59) DYRK1ACLK4GAANISCHMAPT
SCHEMBL2576593 0.73 DYRK1A (0.54) DYRK1ACLK4NOTUMKMT2ANISCH
SCHEMBL16806035 0.73 DYRK1A (0.50) DYRK1ACLK4GAATP53HPGD
SCHEMBL29489425 0.72 CYP3A4 (0.73) DYRK1ACLK4NOTUMGAAKMT2A
SCHEMBL196765 0.72 CYP3A4 (0.73) DYRK1ACLK4NOTUMGAAKMT2A
SCHEMBL29133150 0.72 S1PR1 (0.39) HPGDMAPTALDH1A1MAOB
SCHEMBL30622149 0.72 S1PR1 (0.39) HPGDMAPTALDH1A1MAOB
SCHEMBL9380466 0.71 DYRK1A (0.51) DYRK1ACLK4NOTUMTP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109311902-A Substituted imidazo [1,2-b] pyridazine, substituted imidazo [1,5-b] pyridazine, related compound and their purposes in treatment medical disorder 溶酶体治疗股份有限公司 2019-02-05 CN disclosed